The much-hyped Sterling Biotech case, linked to the Sandesara family of businessmen, has finally closed with a total recovery of around ₹9,800 crore (approximately $1.2 billion), significantly exceeding the initial amount claimed of ₹5,383 crore.
The Sandesara family, including Nitin and Chetan Sandesara, were at the center of this case related to bank loans and their company's activities in India.
The Supreme Court of India has ordered the closure of all legal proceedings, including investigations by key agencies like the CBI, ED and SFIO, confirming a complete and final settlement between the parties.
With the banks now fully compensated and all liabilities discharged, this settlement is considered one of the largest in India's corporate history. The case is expected to serve as a positive precedent for handling and resolving financial disputes in the future, strengthening confidence in the country's banking and legal systems.
The Sandesaras, who fled India around 2017 with Albanian passports after being accused of defaulting on bank loans, have faced multiple investigations for involvement in fraud, embezzlement and money laundering.
